Genfit (FRA:XUPB) Short Interest


FRA:XUPB Genfit SA FRA:XUPB
70 GF Score
Price €6.15
GF Value €4.93
! 10 Warning Signs
View Full Analysis

What is Genfit Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:XUPB vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Genfit's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genfit Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genfit's Short Interest distribution charts can be found below:

* The bar in red indicates where Genfit's Short Interest falls into.


FRA:XUPB
70GF Score
Genfit SA FRA:XUPB
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Genfit (FRA:XUPB) Overvalued in 2026?

Based on GuruFocus' analysis, Genfit stock appears to be overvalued. The current stock price of €6.15 is trading 24.7% above its estimated GF Value™ of €4.93.

Key valuation signals for FRA:XUPB:

  • Short Interest:
  • GF Value™: €4.93 vs. price of €6.15 (24.7% above fair value)
  • GF Score™: 70/100 with 10 warning signs

No single metric tells the full story. See the FRA:XUPB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genfit Business Description

Address 885, Avenue Eugene Avinee, Parc Eurasante, Loos, FRA, 59120
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements to fund the further development of its products. It has one segment, the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
70GF Score

Get the complete analysis for FRA:XUPB

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.15
Price
€4.93
GF Value